Rocket


News + Filings
Holdings





All
13F
13D/G
Other



Bain Capital Life Sciences Fund, L.P. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/08/2023 144 Form 144 - Report of proposed sale of securities:
05/30/2023 3 Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Annexon, Inc.
05/30/2023 4 Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Annexon, Inc.
Txns: Bought 300,000 shares @ $2.1324, valued at $639.7k
05/30/2023 SC 13G/A Bain Capital Life Sciences Fund, L.P. reports a 5.5% stake in Annexon, Inc.
05/18/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2023 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2023 SC 13G/A Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for Annexon, Inc.
02/14/2023 SC 13G/A Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc.
11/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/17/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/15/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/08/2022 SC 13D/A Bain Capital Life Sciences Fund, L.P. reports a 4.5% stake in ARCUTIS BIOTHERAPEUTICS, INC.
05/27/2022 SC 13D/A Bain Capital Life Sciences Fund, L.P. reports a 5.3% stake in ARCUTIS BIOTHERAPEUTICS, INC.
05/16/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2022 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
02/14/2022 SC 13G/A Bain Capital Life Sciences Fund, L.P. has filed a Schedule 13D for X4 Pharmaceuticals, Inc.
02/14/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/27/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/16/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
08/11/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/21/2021 4 Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns: Converted 6,999,998 shares @ $0
Converted 1,334,562 shares @ $0
Bought 100,000 shares @ $20, valued at $2M
Converted 35,000,001 options to buy @ $0
Converted 6,672,819 options to buy @ $0
07/14/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
06/11/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/17/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
03/26/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/19/2021 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G Bain Capital Life Sciences Fund, L.P. reports a 7.7% stake in Annexon, Inc.
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 13F-NT Form 13F-NT - Quarterly report filed by institutional managers, Notice:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy